News
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months. Called Yeztugo, the highly effective drug has ...
(AP Photo / Nardus Engelbrecht ) American biopharmaceutical major Gilead Sciences, has recieved approval ... to be marketed as ‘Yeztugo’. Gilead shares briefly jumped 3.5 per cent — its ...
4don MSN
The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results